Mr. Kevin McLaughlin is a finance and management executive with more than 40 years of experience in the biopharma and high-tech industries. He was most recently the senior vice president, chief financial officer and treasurer with Acceleron Pharma. During his 11-year tenure, he was a key member of management that helped to drive the company’s growth from a private research-focused business to a publicly traded commercial entity that Merck acquired for $11.5 billion. Mr. McLaughlin also serves as a director of Vericel Corporation and Decibel Therapeutics. He also serves on the boards of Vericel Corporation (VCEL) and Decibel Therapeutics, Inc. (DBTX). Mr. McLaughlin earned a B.S. in accounting and physical distribution management from Northeastern University and an MBA from Babson College.